Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (2): 171-175    DOI: 10.31083/j.ejgo.2020.02.5040
Original Research Previous articles | Next articles
Surgical complications and survival after pelvic exenteration: our experience following 60 procedures
M.E. Căpîlna1, B. Szabo1, J. Becsi1, M. Morariu1, M. Gheorghe1, *(), S.L. Kiss1, B. Moldovan2
1 First Obstetrics and Gynecology Clinic, University of Medicine and Pharmacy, Târgu-Mureş, Romania
2 Department of Surgery, "St. Constantin" Hospital, Braşov, Romania
Download:  PDF(720KB)  ( 252 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of Investigation: Analyse the results of pelvic exenteration for pelvic malignancies in a tertiary referral center. Materials and methods: Between 2011 and 2018, 60 patients underwent a pelvic exenteration. The indications were cervical (44 patients), vaginal (4), recurrent ovarian (6), endometrial (2), vulval (2), recurrent sigmoid colon (1), and bladder cancer (1). Results: Out of the 60 exenterations, 31 were total, 21 anterior, and 8 posterior. A Bricker non-continent ileal or sigmoid urinary conduit was performed in 51 out of 52 anterior and total exenterations. Early complications occurred in 34 patients of whom four perioperative deaths (6.6 %). Among the 60 patients, at this moment, 33 are alive, 25 are dead, and two are lost to follow-up. Conclusion: Pelvic exenteration for recurrent or advanced pelvic malignancies can be associated with long-term survival and even cure without high perioperative mortality in properly selected patients. However, postoperative complications can be lethal.
Key words:  Complications      Pelvic exenteration      Survival     
Published:  15 April 2020     
*Corresponding Author(s):  M. GHEORGHE     E-mail:  mihai18go@gmail.com

Cite this article: 

M.E. Căpîlna, B. Szabo, J. Becsi, M. Morariu, M. Gheorghe, S.L. Kiss, B. Moldovan. Surgical complications and survival after pelvic exenteration: our experience following 60 procedures. European Journal of Gynaecological Oncology, 2020, 41(2): 171-175.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.02.5040     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I2/171

[1] Ji Geun Yoo, Hae Nam Lee, Sung Jong Lee, Jin Hwi Kim, Yong Seok Lee, Ahwon Lee, Soo Young Hur, Keun Ho Lee. Germline BRCA2 mutation is associated with greater progression-free survival in korean women with advanced high-grade serous ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 675-680.
[2] Silvia Ortega, José Angel Mínguez, José Manuel Aramendía, Marta Santisteban, Fernando Martinez-Regueira, Pablo Martí-Cruchaga, Juan Luis Alcázar, Matías Jurado. The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 523-530.
[3] Krittiya Somaketarin, Charuwan Tantipalakorn, Kittipat Charoenkwan, Prapaporn Suprasert, Jatupol Srisomboon. Survival outcomes of sex cord-stromal tumors of the ovary[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 563-568.
[4] Sigit Purbadi, Gregorius Tanamas, Lisa Novianti. Advanced stage ovarian cancer survival in Jakarta[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 587-590.
[5] Chenchen Zhu, Hanyuan Liu, Zhen Shen, Yanhu Xie, Tianjiao Zhang, Björn Nashan, Dabao Wu, Ying Zhou. Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 415-421.
[6] Xiaofeng Xu, Xuan Zhou, Yijin Wang, Tao Liu, Jian Fu, Qian Yang, Jun Wu, Huaijun Zhou. Survival-associated transcriptome analysis in ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 455-461.
[7] Can Fang, Yan Zhao, Kezhen Li, Danhui Weng, Peng Wu, Gang Chen, Ding Ma, Juncheng Wei. Diabetes mellitus and epithelial ovarian cancer in Chinese women: a retrospective cohort study[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 260-264.
[8] S. Srdelić Mihalj, V. Čapkun, I. Kuzmić-Prusac. High-grade endometrial cancer survival (endometrioid to non-endometrioid histology comparison)[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 16-22.
[9] H. Imafuku, Y. Ebina, K. Suzuki, S. Wakahashi, Y. Miyahara, K. Yoshida, H. Yamada. Definitive radiotherapy in elderly patients and patients with locally advanced cervical cancer with complications[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 60-64.
[10] S.H. Nam, H.R. Yang, D. Kang, K.O. Jung, W.Y. Kim. Survival of advanced epithelial ovarian/fallopian tube/primary peritoneum carcinoma after high-complexity upper abdominal surgery[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 970-976.
[11] Z. Zheng, Z.H. Han, Z.T. Li, X.H. Wu. The impact of laparoscopic surgical treatments on oncologic outcome of Stage I uterine leiomyosarcoma[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 977-981.
[12] S. Dierckxsens, B. Geerinckx, M.T. Huizing, W.A.A. Tjalma. A review regarding the feasibility and accuracy of a sentinel lymph node biopsy after neo-adjuvant chemotherapy for breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 714-721.
[13] H. Oikiri, M. Futagami, J. Watanabe, Y. Yokoyama. Adenocarcinoma of the cervix: its prognosis and difficult pathological diagnosis[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 728-733.
[14] G. Scandurra, S. Gieri, F. Marletta, B. Pecorino, S. Nicolini, G. L. Banna, G. Scibilia, P. Scollo. Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrent ovarian cancer patients with BRCA1/2 mutation[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 739-743.
[15] A. Mladěnka, P. Mladěnka, O. Simetka, J. Klát. Intra-operative and postoperative complications depend on operating approach and body mass index in patients with malignant uterus body neoplasm[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 593-598.
No Suggested Reading articles found!